p53 Activator 2 is used as an anticancer agent that intercalates into DNA, inducing significant double-strand breaks; it upregulates p53, phosphorylated p53, CDK4, and p21, leading to G2/M cell cycle arrest; it promotes apoptosis and downregulates anti-apoptotic proteins Bcl-2, Bcl-xL, and cyclin B1; it exhibits antiproliferative activity against MGC-803 cells (IC50 = 1.73 µM) and demonstrates potent antitumor efficacy in MGC-803 xenograft models.